An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients

This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Kidney Transplantation

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Belgrade, Serbia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients, >/= 18 years of age
Recipients of renal allograft
Patients receiving CellCept

Exclusion criteria

Treatment and study plan

Primary outcomes

Average dose of CellCept used in immunosuppressive protocols in Serbia

Time frame: 9 months
Average dose of concomitant immunosuppressive drugs

Time frame: 9 months

Secondary outcomes

Average duration of post-transplant period for patients in Serbia receiving CellCept

Time frame: 9 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol

Important dates

Study start: 2009
Primary completion: 2011
Study completion: 2011
First posted: Oct 16, 2012
Registry last updated: Nov 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed